Triferic AVNU
These highlights do not include all the information needed to use TRIFERIC AVNU safely and effectively. See full prescribing information for TRIFERIC AVNU. TRIFERIC AVNU (ferric pyrophosphate citrate injection), for intravenous use Initial U.S. Approval: 2015
Approved
Approval ID
51197a48-6078-42cd-b5ed-5ea22b6757b4
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 15, 2020
Manufacturers
FDA
Rockwell Medical Inc.
DUNS: 933721433
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ferric pyrophosphate citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code57278-318
Application NumberNDA212860
Product Classification
M
Marketing Category
C73594
G
Generic Name
ferric pyrophosphate citrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 15, 2020
FDA Product Classification
INGREDIENTS (1)
FERRIC PYROPHOSPHATE CITRATEActive
Quantity: 1.5 mg in 1 mL
Code: UBY79OCO9G
Classification: ACTIM